跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CEFUROXIME-AFT POWDER FOR INJECTION 250MG/VIAL - HSA Drug Approval Details
Approvals
/
HSA
/
CEFUROXIME-AFT POWDER FOR INJECTION 250MG/VIAL
Approved
THERAPEUTIC
CEFUROXIME-AFT POWDER FOR INJECTION 250MG/VIAL
QILU PHARMACEUTICAL CO., LTD. (CHINA)
🇸🇬 Health Sciences Authority
Approval Date
Jan 12, 2017
Approval ID
24edf99ec4c61c7a
Company
QILU PHARMACEUTICAL CO., LTD. (CHINA)
Type
Therapeutic
Approval Details
Approval Id
24edf99ec4c61c7a
Drug Name
CEFUROXIME-AFT POWDER FOR INJECTION 250MG/VIAL
Product Name
CEFUROXIME-AFT POWDER FOR INJECTION 250MG/VIAL
Approval Number
SIN15156P
Approval Date
2017-01-12
Registrant
APEX PHARMA MARKETING PTE. LTD.
Licence Holder
APEX PHARMA MARKETING PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
INJECTION, POWDER, FOR SOLUTION
Route Of Administration
INTRAVENOUS, INTRAMUSCULAR
Atc Code
J01DC02
Atc Item Name
cefuroxime
Pharma Manufacturer Name
APEX PHARMA MARKETING PTE. LTD.
Company Detail Path
/organization/apex-pharma-marketing-pte-ltd
Active Ingredients
Cefuroxime sodium 263mg eqv Cefuroxime
250mg
Cefuroxime sodium 263mg eqv Cefuroxime
250mg
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jan 12, 2017
Approval ID
24edf99ec4c61c7a
Type
Therapeutic
Back to HSA Approvals
